Home/Filings/4/0001461959-19-000001
4//SEC Filing

Rosenstadt William S 4

Accession 0001461959-19-000001

CIK 0001596062other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:32 PM ET

Size

11.6 KB

Accession

0001461959-19-000001

Insider Transaction Report

Form 4
Period: 2019-06-05
Rosenstadt William S
DirectorGeneral Counsel10% Owner
Transactions
  • Award

    Incentive Stock Options

    2019-06-05+50,0001,150,000 total
    Exercise: $1.25Exp: 2024-06-05Common Stock (50,000 underlying)
  • Award

    Incentive Stock Options

    2019-10-16+173,6411,423,461 total
    Exercise: $0.86From: 2020-04-16Exp: 2024-10-16Common Stock (173,461 underlying)
  • Award

    Common Stock

    2019-10-16+115,761618,761 total
  • Award

    Incentive Stock Options

    2019-06-05+100,0001,250,000 total
    Exercise: $1.25Exp: 2024-06-05Common Stock (100,000 underlying)
Footnotes (5)
  • [F1]Issued for legal consulting services.
  • [F2]These options vest in 4 equal installments of 12,500 each, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The first installment vested on June 5, 2019.
  • [F3]Issued for director services.
  • [F4]These options vest in 4 equal installments of 25,000 each, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The first installment vested on June 5, 2019.
  • [F5]Issued for officer services.

Issuer

Q BioMed Inc.

CIK 0001596062

Entity typeother

Related Parties

1
  • filerCIK 0001461959

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:32 PM ET
Size
11.6 KB